Pharmaceutical Affairs Law and Deregulation of Cosmetics

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Competition law, competition policy, and deregulation

Nykvist, from an anonymous referee and from the editors of this journal.

متن کامل

Program in Law and Public Affairs

This paper examines the effect of judicial ideology on the selection and outcome of telecommunications regulatory cases. Using a dataset on Federal Communications Commission orders and trials from 1990 to 1995, this paper shows that changes in the make-up of the bench of the D.C. Circuit Court of Appeals affects not only who wins the cases, but also the cases selected for litigation. Specifical...

متن کامل

Psychiatry, the law, and public affairs.

The law is a public affair. The involvement of psychiatrists and psychiatry in legal and judicial proceedings themselves, not to mention the ever-increasing media commentary, is an opportunity to educate the public, but it also entails the very real risk of compounding public misinformation and misgivings about our field. The American Psychiatric Association has both a professional staff Divisi...

متن کامل

Impact of Labor Law Implementation in the Lebanese Pharmaceutical Sector

Labor law implementation has a basic role in increasing employment stability, decreasing turnover, and managing the employer-employee relation, which increases the productivity levels in any organization. In this paper, the importance of implementing the labor law in the Lebanese pharmaceutical sector, in the two main divisions, sales (medical representative) and community pharmacies is discuss...

متن کامل

Do cost-sharing and entry deregulation curb pharmaceutical innovation?

This paper examines the role of both cost-sharing schemes in health insurance systems and the regulation of entry into the pharmaceutical sector for pharmaceutical R&D expenditure and drug prices. The analysis suggests that both an increase in the coinsurance rate and stricter price regulations adversely affect R&D spending in the pharmaceutical sector. In contrast, entry deregulation may lead ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of the Japan Society of Colour Material

سال: 2001

ISSN: 0010-180X

DOI: 10.4011/shikizai1937.74.247